University Hospital Of Canary Islands — Clinical Trial Site

36 Registered trials

13 Currently recruiting

Organisation

University Hospital Of Canary Islands

Location

San Cristobal De La Laguna, Spain

Identifier

ORG-100031202

Address

Carretera De La Cuesta Taco S/n, Cuesta La, 38320, Spain

Departments

#034022 Oncología Médica
#3433: Endocrinología
#40401:Reumatología
1219:Oncología Médica
Alergology
Allergology
Hematology
Medical Oncology
Nefrology
Oncología
Oncology
Pediatric oncology and hematology
Rheumatology
Rheumatology Department
Servicio Oncologia Medica
Servicio de Endocrinología
Servicio de Enfermedades Infecciosas
Servicio de Oncología Médica
Servicio de Oncología y Hematología Pediátricas
Urology

Clinical trials at this site (36)

Search interface

Study of neoadjuvant patritumab deruxtecan with or without endocrine therapy in previously untreated patients – VALENTINE trial Ended

2023-503403-28-00 treatment naïve patients with HR+/HER2-negative high-ri 4 2022-11-25
A clinical trial to compare the effectiveness and safety of giredestrant with a subcutaneous combination of pertuzumab and trastuzumab versu… Ended

2022-500014-26-00 Locally-Advanced unresectable or Metastatic breast canc 5 2022-06-24
A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended

2023-506368-14-00 Systemic lupus erythematosus (SLE) 5 2021-09-07
Pre- and post-menopausal women or men with advanced (loco-regionally recurrent not amenable to curative therapy or metastatic) HER2-positive… Ended

2023-508829-28-00 Pre- and post-menopausal women or men with advanced (lo 4 2021-03-15
Study of Biological Effect in Tumor Samples from Clinical Trial Patients Treated with Ds8201 Ended

2023-508830-33-00 Patients diagnosed with advanced or metastatic cancer t 4 2019-12-13
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive,… Ended

2024-516847-23-00 ER-positive and HER2-negative metastatic or locally adv 4 2019-08-27
Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo®… Ended

2023-507865-24-00 Advanced (unresectable/metastatic) melanoma 5 2025-03-28
A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight Ended

2022-502531-18-00 Obesity 5 2024-01-18
A study to find out if daridorexant is safe and efficacious to treat insomnia in patients with insomnia and comorbid nocturia Ended

2022-501246-30-00 Insomnia Disorder 6 2023-03-08
Advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer Ended

2023-508828-35-01 Patients with advanced hormone receptor-positive/HER2- 5 2022-03-28
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 Chronic Lymphocytic Leukemia (CLL) 5 2014-12-18